BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4136824)

  • 21. [Studies on the effects of compound 48-80 on complement activity].
    Yamamoto S
    Arerugi; 1969 Jan; 18(1):70-80. PubMed ID: 4181010
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-complementary activity for guinea-pig and sheep complement in serum and Mg2+ EGTA plasma from various animals.
    Stankiewicz M; Jonas W; Pulford H
    N Z Vet J; 1981 Jun; 29(6):107-8. PubMed ID: 6796918
    [No Abstract]   [Full Text] [Related]  

  • 23. An explanation for the inefficiency of guinea pig complement in the cytolysis of sheep erythrocytes or rat mast cells sensitized with rabbit antiserum: a double block.
    Kempf RA; Gigli I; Austen KF
    Transplant Proc; 1969 Mar; 1(1):626-8. PubMed ID: 4109231
    [No Abstract]   [Full Text] [Related]  

  • 24. Complement in clinical medicine.
    Frank MM; Atkinson JP
    Dis Mon; 1975 Jan; ():1-54. PubMed ID: 46195
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence that rabbit gamma G haemolysin in capable of utilizing guinea-pig complement more efficiently than rabbit gamma M haemolysin.
    Frank MM; Gaither T
    Immunology; 1970 Dec; 19(6):975-81. PubMed ID: 5487544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The enzymatic measurement of binding of first component of guinea pig complement with formalized sheep erythrocytes sensitized with rabbit antiserum.
    Mori Y; Kawai N; Koyama J
    J Biochem; 1973 May; 73(5):951-8. PubMed ID: 4737266
    [No Abstract]   [Full Text] [Related]  

  • 27. [The third component of complement and complement receptors (author's transl)].
    Okuda T; Tachibana T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(9):657-67. PubMed ID: 4215099
    [No Abstract]   [Full Text] [Related]  

  • 28. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement: a reversible temperature-dependent alteration in the reactivity of EAC1 with C4.
    Linscott WD
    J Immunol; 1973 Jul; 111(1):200-11. PubMed ID: 4197334
    [No Abstract]   [Full Text] [Related]  

  • 30. [In vitro inhibitory effect of phenylbutazone on the hemolytic activity of complement in guinea pigs].
    Lang JM; Hainaut J
    Agressologie; 1972; 13(2):117-20. PubMed ID: 5078837
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of guinea pig complement by aromaticamidine and guanidine compounds.
    Bing DH
    J Immunol; 1970 Nov; 105(5):1289-91. PubMed ID: 5489072
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. I. Antibody and serum requirements.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1671-7. PubMed ID: 4750864
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of guinea pig complement by maleopimaric acid and other derivatives of levopimaric acid.
    Glovsky MM; Becker EL; Halbrook NJ
    J Immunol; 1968 May; 100(5):979-90. PubMed ID: 5648478
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of rheumatoid factor on complement-mediated phagocytosis.
    McDuffie FC; Brumfield HW
    J Clin Invest; 1972 Dec; 51(12):3007-14. PubMed ID: 4640945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic aspects of diseases of complement: an explosion.
    Polley MJ; Bearn AG
    Am J Med; 1975 Jan; 58(1):105-11. PubMed ID: 46701
    [No Abstract]   [Full Text] [Related]  

  • 37. Irreversible enzyme inhibitors. 180. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine and phenoxyacetamide.
    Baker BR; Cory M
    J Med Chem; 1971 Feb; 14(2):119-25. PubMed ID: 5544395
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of zinc and cadmium on guinea-pig complement.
    Amiraian K; McKinney JA; Duchna L
    Immunology; 1974 Jun; 26(6):1135-44. PubMed ID: 4851716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of complement-mediated membrane damage: the influence of erythrocyte storage on susceptibility to cytolysis.
    Gaither TA; Frank MM
    J Immunol; 1973 Feb; 110(2):482-9. PubMed ID: 4684035
    [No Abstract]   [Full Text] [Related]  

  • 40. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
    Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR
    Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.